Morten Duesund • 1970 • Lillestrøm • 9 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
M MODUS I AS	Managing Director/CEO	-	22,195	100 % directly
M MODUS X AS	Managing Director/CEO	146,102	110,283	100 % directly
O ONCOGENE AS	Managing Director/CEO	-	36,772	52 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
M MODUS X AS	Chairman	146,102	110,283	100 % directly
M MODUS I AS	Chairman	-	22,195	100 % directly
O ONCOGENE AS	Chairman	-	36,772	52 % indirectly
M MOLAR AS	Chairman	-	407,021	32 % directly
K KJELLER TANNHELSE AS	Chairman	16,305,853	935,560	31.2 % indirectly
Ø ØYTANGEN HYTTEVEL	Chairman	-	-	-

Last update: Aug 2, 2024

Related industries3

Professional, scientific and technical activities
Human health and social work activities
Other service activities

Direct relationships5

TB
Trine Bjelke-Holtermann1973
MOLAR AS, KJELLER TANNHELSE AS
IC
Ida Christine Filtenborg Hansen1989
ONCOGENE AS
AT
Alf Torbjørn Mehli1949
ØYTANGEN HYTTEVEL
CK
Charitra Kumar Mishra1978
ONCOGENE AS
TH
Tore Helge Rismyhr1962
ONCOGENE AS

Shares owned by Morten Bjelke-Holtermann Duesund

Name	Share class	Total operating income	Total equity	Share
M MODUS X AS	Ordinære aksjer	146,102	110,283	100 % directly
M MODUS I AS	Ordinære aksjer	0	22,195	100 % directly
O ONCOGENE AS		0	36,772	52 % indirectly
M MOLAR AS	Ordinære aksjer	0	407,021	32 % directly
K KJELLER TANNHELSE AS		16,305,853	935,560	31.2 % indirectly
R REC SILICON ASA	NO0010112675	0	244,083,000	< 0.01 % directly
N NORWEGIAN AIR SHUTTLE ASA	NO0010196140	822,000,000	11,015,000,000	< 0.01 % directly
S SCATEC ASA	NO0010715139	6,271,000,000	10,297,000,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024